Rationale for the use of genistein-conta
โ
Stephen Barnes; T. Greg Peterson; Lori Coward
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 701 KB
Pharmacologists have realized that tyrosine kinase inhibitors (TKI) have potential as anticancer agents, both in prevention and therapy protocols. Nonetheless, concern about the risk of toxicity caused by synthetic TKIs restricted their development as chemoprevention agents. However, a naturally occ